Pan Am Farma

Aflibercept  100mg

Aflibercept 100mg

Contact for Quote
  • Brand Names: EYLEA®, Zaltrap
  • Form: Single-dose vials for intravenous or intravitreal use
  • Strength: 100 mg/4 mL (25 mg/mL) S
  • Manufacturer: Sanofi‑Aventis
  • Country: Germany/Mexico/India
  • MOQ: 10 Vials
  • Shelf Life: 24 Months
  • Lead Time: 7 to 10 Days
  • Storage: 2–8 °C; protect from light; do not freeze

Description

Indications & Use: Intravitreal 2 mg injection for wet AMD, DME, DR, RVO, ROP; IV 100 mg/4 mL with FOLFIRI for metastatic colorectal cancer. Aflibercept is being researched for its potential to inhibit angiogenesis in VEGF-expressing breast cancers, particularly triple-negative breast cancer, through targeted delivery of anti-VEGF therapy.

Shopping cart0
There are no products in the cart!
Continue shopping
Productos